Industry News
A 2026 procurement guide for tirzepatide peptide buyers: 5 objective criteria including purity >99%, 7–10 day lead time, risk control, after-sales service, and export track record. Includes case study of a 50,000-vial US order.
Industry News
A 2026 procurement guide for tirzepatide peptide buyers. Learn how to evaluate suppliers based on purity, certification, delivery speed, risk control, and export experience. Profiles of Yee Peptide, Bachem, and GL Biochem with key metrics.
Industry News
A practical 2026 how-to guide for procurement professionals on evaluating and selecting high-purity tirzepatide peptide suppliers for metabolic disease and weight management research.
Industry News
A technical 2026 procurement guide for evaluating Tirzepatide vial suppliers. Learn key criteria on quality control, manufacturing capacity, risk mitigation, and supplier comparison for metabolic research.
Industry News
A 2026 market analysis of high-purity Tirzepatide peptide suppliers. Explore the competitive landscape, key trends in GLP-1/GIP dual agonists, and a detailed comparison of leading manufacturers including Yee Peptide's integrated solutions.
Industry News
A professional guide comparing the top 3 Chinese Tirzepatide peptide suppliers in 2026: Yee Peptide, GenScript, and CPC. Analysis covers scale, technology, quality, and market focus for sourcing high-purity Tirzepatide for obesity and diabetes research.
Industry News
On September 29, 2025, Wanbangde Biotech announced that its independently developed MCR cyclic peptide has shown superior weight-loss and metabolic regulation effects compared to existing GLP-1 drugs in preclinical studies.
Industry News
On April 1, 2026, the 2026 Peptide Industry Technology Innovation Summit was held in Ningxiang, Hunan.
